Literature DB >> 33000648

Depression, perceived stress related to COVID, post-traumatic stress, and insomnia among asthma and COPD patients during the COVID-19 pandemic.

John Carlos Pedrozo-Pupo1, Adalberto Campo-Arias1.   

Abstract

INTRODUCTION: The COVID pandemic has had a high psychological impact on healthy populations. Increased levels of perceived stress, depression, and insomnia are expected, especially in people with pre-existing medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), who seem to be particularly vulnerable. However, the difference in psychological distress frequency between asthma and COPD patients is unknown.
OBJECTIVE: To compare the prevalence of depression, perceived stress related to COVID, post-traumatic stress, and insomnia in asthma and COPD patients at a pulmonology clinic in Santa Marta, Colombia.
METHODS: A cross-sectional study was designed. The patients were contacted by telephone. An electronic link was sent to those who accepted. The questionnaire asked for perceived stress related to COVID-19, post-traumatic stress symptoms, depressive symptoms, and insomnia risk.
RESULTS: 148 asthma patients and 144 COPD patients participated in, between 18 and 96 years. The prevalence of high COVID-19 perceived stress was 10.6% (n = 31); post-traumatic stress risk, 11.3% (n = 33); depression risk, 31.5% (n = 92); and insomnia risk, 57.7% (n = 169). No significant differences were found between asthma and COPD in indicators of psychological distress.
CONCLUSIONS: Asthma and COPD patients present similar frequencies of depression risk, COVID-19 perceived stress, post-traumatic stress risk, and insomnia risk during the Colombian lockdown. It is essential to evaluate and manage psychological distress among asthma and COPD patients. It can reduce the risk of exacerbation and improve the quality of life.

Entities:  

Keywords:  COPD; Depression; asthma; insomnia; stress

Mesh:

Year:  2020        PMID: 33000648      PMCID: PMC7533953          DOI: 10.1177/1479973120962800

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


Introduction

The COVID pandemic has had a high psychological impact on healthy populations; it has increased the reporting of depression, perceived stress, post-traumatic stress, and insomnia.[1] Increased levels of perceived stress, depression, and insomnia are expected, especially in people with pre-existing medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), who seem to be particularly vulnerable.[2] The COVID pandemic configures a significant stressor due to the changes associated with confinement, stay at home, physical distancing, and daily routine changes. Stressors can increase the risk of exacerbation and fatal outcome in people with pulmonary morbidity.[3] It was hypothesized that COPD patients would present more considerable psychological distress than asthma patients based on disease features.[4] The study aimed to compare the prevalence of depression, perceived stress related to COVID, post-traumatic stress, and insomnia in asthma and COPD patients at a pulmonology clinic in Santa Marta, Colombia.

Methods

A cross-sectional study was designed; it was approved by the Research Ethics Committee of the University of Magdalena, Santa Marta, Colombia (Act 002 of March 26th, 2020). Asthma and COPD adult outpatients gave informed consent and participated in the study, as stipulated in the Declaration of Helsinki. The patients were contacted by telephone. An electronic link was sent to those who accepted. The questionnaire asked for demographic information and completed four scales: Perceived Stress Related to COVID-19 (α = 0.87), cut-off point 25 for high perceived stress[5]; Brief Davidson Trauma Scale (α = 0.81), cut-off point 12 for post-traumatic stress risk[6]; Patient Health Questionnaire, PHQ-9 (α = 0.87), cut-off point 7 for depression risk[7]; and Athens Insomnia Scale (α = 0.84), cut-off point 6, insomnia risk.[8] Crude odds ratios (OR) were calculated, and after ORs were adjusted for age and gender.

Results

Three hundred seven patients was contacted, and 227 (90.2%) accepted to participate in, 148 asthma patients and 144 COPD patients. The ages were between 18 and 96 years (M = 60.4, SD = 17.6); COPD patients were significantly older than asthma patients (M = 70.8, SD = 11.4 versus M = 50.4, SD = 16.7; t = 12.2, df = 290, p < 0.001). By gender, 189 women (64.7%) and 139 men (35.3%); the female group was over-represented in the asthma group (71.6% versus 57.6%, p = 0.01). The prevalence of high COVID-19 perceived stress was 10.6% (n = 31); post-traumatic stress risk, 11.3% (n = 33); depression risk, 31.5% (n = 92); and insomnia risk, 57.7% (n = 169). See Table 1 presents no significant differences between asthma and COPD in indicator of psychological distress.
Table 1.

Comparison of psychological distress indicators between asthma and COPD patients.

VariableCOPDAsthmaOR (95%CI)
n (%)n (%)CrudeAdjusteda
Depression risk39 (28.5)46 (32.9)0.81 (0.49–1.36)0.81 (0.44–1.48)
High perceived stressb 12 (8.8)16 (14.4)0.74 (0.34–1.64)1.00 (0.39–2.55)
Post-traumatic stress risk14 (10.2)15 (10.7)0.95 (0.44–2.05)0.92 (0.37–2.26)
Insomnia risk71 (51.8)85 (60.7)0.70 (0.43–1.12)0.96 (0.54–1.71)

a Adjusted by age and gender.

b Related to COVID.

Comparison of psychological distress indicators between asthma and COPD patients. a Adjusted by age and gender. b Related to COVID.

Discussion and conclusion

The present analysis was observed a similar frequency of high COVID-19 perceived stress, post-traumatic stress risk, depression risk, and insomnia risk among asthma and COPD patients during the Colombian COVID lockdown. This finding is comparable to a previous study before the COVID pandemic; it was observed that scores for psychological distress were similar among asthma and COPD patients.[9] Conversely, other researchers reported that COPD patients reporting frequent mental distress because it was related to more common physical distress, disability, limitations, or requiring special equipment.[4] It is essential to evaluate and manage psychological distress among asthma and COPD patients. It can reduce the risk of exacerbation and improve the quality of life.[10] This research compares patients with COPD and asthma of the frequency of some psychological distress indicators during the Colombian lockdown; nevertheless, there are some limitations. First, COPD and asthma patients had no control group from the general population. Second, the results cannot be generalized due to the sampling strategy. In conclusion, asthma and COPD patients present similar frequencies of depression risk, COVID-19 perceived stress, post-traumatic stress risk, and insomnia risk during the Colombian lockdown.
  7 in total

1.  Evaluation of psychological status in patients with asthma and COPD.

Authors:  Amir M H Asnaashari; Ali Talaei; Baghban Haghigh
Journal:  Iran J Allergy Asthma Immunol       Date:  2012-03       Impact factor: 1.464

Review 2.  Integrative Medicine for Respiratory Conditions: Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Gloria Y Yeh; Randy Horwitz
Journal:  Med Clin North Am       Date:  2017-06-21       Impact factor: 5.456

3.  Perceived stress associated with COVID-19 epidemic in Colombia: an online survey.

Authors:  John Carlos Pedrozo-Pupo; María José Pedrozo-Cortés; Adalberto Campo-Arias
Journal:  Cad Saude Publica       Date:  2020-06-01       Impact factor: 1.632

4.  Outpatient pulmonary rehabilitation for severe asthma with fixed airway obstruction: Comparison with COPD.

Authors:  Agnès Bellocq; Wanda Gaspard; Camille Couffignal; Marie Vigan; Antoine Guerder; Julien Ambard; Sylvie Caruana; Thomas Similowski; Gilles Garcia; Camille Taillé
Journal:  J Asthma       Date:  2019-01-29       Impact factor: 2.515

5.  Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment.

Authors:  Roy A Pleasants; Jill A Ohar; Janet B Croft; Yong Liu; Monica Kraft; David M Mannino; James F Donohue; Harry L Herrick
Journal:  COPD       Date:  2013-10-23       Impact factor: 2.409

6.  Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria.

Authors:  C R Soldatos; D G Dikeos; T J Paparrigopoulos
Journal:  J Psychosom Res       Date:  2000-06       Impact factor: 3.006

7.  COVID-19 and mental health: A review of the existing literature.

Authors:  Ravi Philip Rajkumar
Journal:  Asian J Psychiatr       Date:  2020-04-10
  7 in total
  12 in total

1.  Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.

Authors:  Vincenzo Patella; Corrado Pelaia; Roberta Zunno; Girolamo Pelaia
Journal:  Respir Med       Date:  2022-06-27       Impact factor: 4.582

Review 2.  The Spill-Over Impact of the Novel Coronavirus-19 Pandemic on Medical Care and Disease Outcomes in Non-communicable Diseases: A Narrative Review.

Authors:  Ivy Lynn Mak; Eric Yuk Fai Wan; Teenie Kwan Tung Wong; Wendy Woo Jung Lee; Esther Wai Yin Chan; Edmond Pui Hang Choi; Celine Sze Ling Chui; Mary Sau Man Ip; Wallace Chak Sing Lau; Kui Kai Lau; Shing Fung Lee; Ian Chi Kei Wong; Esther Yee Tak Yu; Cindy Lo Kuen Lam
Journal:  Public Health Rev       Date:  2022-04-27

Review 3.  Sleep disturbances during the COVID-19 pandemic: A systematic review, meta-analysis, and meta-regression.

Authors:  Haitham A Jahrami; Omar A Alhaj; Ali M Humood; Ahmad F Alenezi; Feten Fekih-Romdhane; Maha M AlRasheed; Zahra Q Saif; Nicola Luigi Bragazzi; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Michael V Vitiello
Journal:  Sleep Med Rev       Date:  2022-01-22       Impact factor: 11.401

4.  Restrictions on healthcare utilization and psychological distress among patients with diseases potentially vulnerable to COVID-19; the JACSIS 2020 study.

Authors:  Emi Takeuchi; Kota Katanoda; Simone Cheli; Gil Goldzweig; Takahiro Tabuchi
Journal:  Health Psychol Behav Med       Date:  2022-02-09

5.  Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan.

Authors:  Muhammad Omair Husain; Imran B Chaudhry; Amy Blakemore; Suleman Shakoor; Muhammad Ali Husain; Steven Lane; Tayyeba Kiran; Farhat Jafri; Rakhshi Memon; Maria Panagioti; Nusrat Husain
Journal:  SAGE Open Med       Date:  2021-10-07

Review 6.  Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic.

Authors:  Jennifer A Sculley; Hugh Musick; Jerry A Krishnan
Journal:  Curr Opin Pulm Med       Date:  2022-03-01       Impact factor: 3.155

7.  Prevalence and variables associated with insomnia among COVID-19 survivors in Colombia.

Authors:  John Carlos Pedrozo-Pupo; Carmen Cecilia Caballero-Domínguez; Adalberto Campo-Arias
Journal:  Acta Biomed       Date:  2022-03-14

8.  Application and implementation of telehealth services designed for the elderly population during the COVID-19 pandemic: A systematic review.

Authors:  Motti Haimi; Anat Gesser-Edelsburg
Journal:  Health Informatics J       Date:  2022 Jan-Mar       Impact factor: 2.681

9.  Sleep problems during COVID-19 pandemic and its' association to psychological distress: A systematic review and meta-analysis.

Authors:  Zainab Alimoradi; Anders Broström; Hector W H Tsang; Mark D Griffiths; Shahab Haghayegh; Maurice M Ohayon; Chung-Ying Lin; Amir H Pakpour
Journal:  EClinicalMedicine       Date:  2021-06-10

10.  Narrative Analysis of the Impact of COVID-19 on Patients with Chronic Obstructive Pulmonary Disease, Their Caregivers, and Healthcare Professionals in Italy.

Authors:  Eleonora Volpato; Stefano Centanni; Paolo Banfi; Salvatore D'Antonio; Enrico Peterle; Filomena Bugliaro; Ignazio Grattagliano; Alessio Piraino; Luca Cavalieri; Alfio Pennisi; Gianluca Danesi; Luigi Santoiemma; Maria Giulia Marini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.